A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia

Addiction

Volumn 98, Issue 11, 2003, Pages 1605-1613

  Ritter, Alison J ^a   Lintzeris, Nicholas ^b   Clark, Nicolas ^a   Kutin, Jozica J ^c   Bammer, Gabriele ^d   Panjari, Mary ^a  

^a TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Forensic Psychiatric Hospital Assen   (Netherlands)

^d The Australian National University   (Australia)

Author keywords

Heroin dependence; LAAM; Maintenance therapy; Methadone maintenance

Indexed keywords

DIAMORPHINE; LEVACETYLMETHADOL; METHADONE; NALOXONE;

ADULT; ARTICLE; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; FEMALE; HEROIN DEPENDENCE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; NAUSEA; OUTCOMES RESEARCH; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; VOMITING; WITHDRAWAL SYNDROME;

ADULT; AUSTRALIA; FAMILY PRACTICE; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; METHADYL ACETATE; MIDDLE AGED; NARCOTICS; OUTCOME ASSESSMENT (HEALTH CARE); TREATMENT OUTCOME;

EID: 0242593827     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2003.00529.x     Document Type: Article

References (23)

1. Bell, D. C., Carlson, J. W. & Richard, A. J. (1998) The social ecology of drug use - a factor analysis of an urban environment. Substance Use and Misuse, 33, 2201-2217.
2. Clark, N., Lintzeris, N., Gisjbers, A., Whelan, G., Dunlop, A., Ritter, A. & Ling, W. (2002) LAAM maintenance vs. methadone maintenance for heroin dependence (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software.
3. Darke, K. & Finlay-Jones, R. (1998) Drug use and injection risk-taking among prison methadone maintenance patients. Addiction, 93, 1169-1175.
4. Darke, S., Ward, J., Hall, W., Heather, N. & Wodak, A. (1991) The Opiate Treatment Index (OTI) Researcher's Manual. Technical Report 11. Sydney: National Drug and Alcohol Research Centre.
5. Department of Health and Community Services (1995) Victorian methadone program. Guidelines for Providers. Melbourne: Victorian Government Department of Health and Community Services.
6. Digiusto, E., Seres, V., Bibby, A. & Batey, R. (1996) Concordance between urinalysis results and self-reported drug use by applicants for methadone maintenance in Australia. Addictive Behaviours, 21, 319-329.
7. Dyer, K. R., Foster, D. J., White, J. M., Somogyi, A. A., Menelaou, A. & Bochner, F. (1999) Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships. Clinical Pharmacology and Therapeutics, 65, 685-694.
8. Dyer, K. R. & White, J. M. (1997) Patterns of symptom complaints in methadone maintenance patients. Addiction, 92, 1445-1455.
9. Eissenberg, T., Stitzer, M. L., Bigelow, G. E., Buchhalter, A. R. & Walsh, S. L. (1997) LAAM is not less potent than methadone: a relative potency comparison of acute agonist effects. Paper presented at the CPDD 1997 Annual Meeting, Nashville, TN.
10. Freedman, R. R. & Czertko, G. (1981) A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts. Drug and Alcohol Dependence, 8, 215-222.
11. Goldstein, A. & Judson, B. A. (1974) Three critical issues in the management of methadone programs. In: Bourne, P. G., ed. Addiction, pp. 129-148. New York: Academic Press.
12. Huber, A., Ling, W., Fradis, J. & Charuvastra, C. (2001) Comparison of the effects of methadone and LAAM on the electrocardiogram. Paper presented at the 63rd annual CPDD scientific meeting. Drug and Alcohol Dependence, 63 (Supp 1), S70.
13. Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stlzer, M. L. & Bigelow, G. E. (2000) A comparison of levomethadyl acetate, buprenorphine, and methadone for oploid dependence. New England Journal of Medicine, 343, 1290-1297.
14. Karp-Gelernter, E., Savage, C. & McCabe, O. L. (1982) Evaluation of clinic attendance schedules for LAAM and methadone: a controlled study. International Journal of Addiction, 17, 805-813.
15. Krantz, M. J., Lewkowiez, M. D., Hays, H., Woodroofe, M. A., Robertson, A. D. & Mehler, P. S. (2002) Torsade de Pointes associated with very-high dose methadone. Annals of Internal Medicine, 137, 501-504.
16. Ling, W., Klett, C. J. & Gillis, R. (1976) Summary of SAODAP Phase II Cooperative Study of LAAM vs methadone. In: Blaine, J. D. & Renault, P. F., eds. Rx:3x/Week LAAM Alternative to Methadone. NIDA Research Monograph Series. Vol. 8, pp. 103-108. Rockville, MD: National Institute on Drug Abuse.
17. Ling, W., Klett, C. J. & Gillis, R. (1978) A cooperative clinical study of methadyl acetate. 1. Three-times-a-week regimen. Archives of General Psychiatry, 35, 345-353.
18. Lintzeris, N., Ritter, A., Dunlop, A. & Muhleisen, P. (2002) Training primary health care professionals to provide buprenorphine and LAAM treatment. Substance Abuse, 23, 245-254.
19. Newmann, M. C., Klett, C. J. & Stillman, R. (1975) Implementing a national study of a new maintenance drug. American Journal of Drug and Alcohol Abuse, 2, 289-300.
20. Senay, E. C., Dorus, W. & Renault, P. F. (1977) Methadyl acetate and methadone. An open comparison. Journal of the American Medical Association, 237, 138-142.
21. Signorini, D. F., Leung, O., Simes, R. J., Beller, E., Gebski, V. J. & Callaghan, T. (1993) Dynamic balanced randomization for clinical trials. Statistics in Medicine, 12, 2343-2350.
22. Stimmel, B. (2001) Maintenance therapy for opioid addiction with methadone. LAAM and buprenorphine: the emperor's new clothes phenomenon. Journal of the Addictive Diseases, 20, 1-5.
23. Walsh, S. L., Johnson, R. E., Cone, E. J. & Bigelow, G. E. (1998) Intravenous and oral 1-alpha-acetylmethadol: pharmacodynamics and pharmacokinetics in humans. Journal of Pharmacological Experimental Therapy, 285, 71-82.